NATIONAL HEALTHCARE CORP (NHC) Stock Fundamental Analysis

NYSEARCA:NHC • US6359061008

157.82 USD
-0.6 (-0.38%)
At close: Feb 20, 2026
157.82 USD
0 (0%)
After Hours: 2/20/2026, 8:04:00 PM
Fundamental Rating

6

NHC gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. NHC scores excellent on profitability, but there are some minor concerns on its financial health. NHC is valued expensive and it does not seem to be growing. NHC also has an excellent dividend rating. This makes NHC very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year NHC was profitable.
  • NHC had a positive operating cash flow in the past year.
  • Each year in the past 5 years NHC has been profitable.
  • NHC had a positive operating cash flow in each of the past 5 years.
NHC Yearly Net Income VS EBIT VS OCF VS FCFNHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 6.44%, NHC belongs to the top of the industry, outperforming 86.27% of the companies in the same industry.
  • The Return On Equity of NHC (9.62%) is better than 69.61% of its industry peers.
  • With a decent Return On Invested Capital value of 7.14%, NHC is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for NHC is significantly below the industry average of 9.00%.
  • The last Return On Invested Capital (7.14%) for NHC is above the 3 year average (3.68%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.44%
ROE 9.62%
ROIC 7.14%
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
NHC Yearly ROA, ROE, ROICNHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • NHC's Profit Margin of 6.75% is amongst the best of the industry. NHC outperforms 85.29% of its industry peers.
  • NHC's Profit Margin has improved in the last couple of years.
  • With a decent Operating Margin value of 8.27%, NHC is doing good in the industry, outperforming 75.49% of the companies in the same industry.
  • NHC's Operating Margin has improved in the last couple of years.
  • The Gross Margin of NHC (38.55%) is better than 68.63% of its industry peers.
  • In the last couple of years the Gross Margin of NHC has remained more or less at the same level.
Industry RankSector Rank
OM 8.27%
PM (TTM) 6.75%
GM 38.55%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
NHC Yearly Profit, Operating, Gross MarginsNHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

  • NHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • NHC has more shares outstanding than it did 1 year ago.
  • NHC has more shares outstanding than it did 5 years ago.
  • NHC has a worse debt/assets ratio than last year.
NHC Yearly Shares OutstandingNHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NHC Yearly Total Debt VS Total AssetsNHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 4.95 indicates that NHC is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.95, NHC belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
  • NHC has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.50, NHC belongs to the top of the industry, outperforming 89.22% of the companies in the same industry.
  • A Debt/Equity ratio of 0.06 indicates that NHC is not too dependend on debt financing.
  • NHC's Debt to Equity ratio of 0.06 is fine compared to the rest of the industry. NHC outperforms 77.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.5
Altman-Z 4.95
ROIC/WACC0.83
WACC8.58%
NHC Yearly LT Debt VS Equity VS FCFNHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

  • NHC has a Current Ratio of 1.75. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
  • NHC's Current ratio of 1.75 is fine compared to the rest of the industry. NHC outperforms 68.63% of its industry peers.
  • A Quick Ratio of 1.72 indicates that NHC should not have too much problems paying its short term obligations.
  • The Quick ratio of NHC (1.72) is better than 72.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.72
NHC Yearly Current Assets VS Current LiabilitesNHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

  • NHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.77%.
  • Measured over the past years, NHC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.03% on average per year.
  • Looking at the last year, NHC shows a very strong growth in Revenue. The Revenue has grown by 21.12%.
  • Measured over the past years, NHC shows a small growth in Revenue. The Revenue has been growing by 5.58% on average per year.
EPS 1Y (TTM)-18.77%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-8.28%
Revenue 1Y (TTM)21.12%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%12.48%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHC Yearly Revenue VS EstimatesNHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

4. Valuation

4.1 Price/Earnings Ratio

  • NHC is valuated rather expensively with a Price/Earnings ratio of 24.35.
  • NHC's Price/Earnings ratio is a bit cheaper when compared to the industry. NHC is cheaper than 62.75% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, NHC is valued at the same level.
Industry RankSector Rank
PE 24.35
Fwd PE N/A
NHC Price Earnings VS Forward Price EarningsNHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NHC is valued a bit cheaper than 66.67% of the companies in the same industry.
  • NHC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NHC is cheaper than 73.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.68
EV/EBITDA 12.25
NHC Per share dataNHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • NHC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.03
EPS Next 2YN/A
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

  • NHC has a Yearly Dividend Yield of 1.62%.
  • Compared to an average industry Dividend Yield of 0.48, NHC pays a better dividend. On top of this NHC pays more dividend than 88.24% of the companies listed in the same industry.
  • NHC's Dividend Yield is comparable with the S&P500 average which is at 1.85.
Industry RankSector Rank
Dividend Yield 1.62%

5.2 History

  • The dividend of NHC has a limited annual growth rate of 3.30%.
  • NHC has paid a dividend for at least 10 years, which is a reliable track record.
  • NHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.3%
Div Incr Years11
Div Non Decr Years11
NHC Yearly Dividends per shareNHC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • NHC pays out 37.72% of its income as dividend. This is a sustainable payout ratio.
  • NHC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.72%
EPS Next 2YN/A
EPS Next 3YN/A
NHC Yearly Income VS Free CF VS DividendNHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M
NHC Dividend Payout.NHC Dividend Payout, showing the Payout Ratio.NHC Dividend Payout.PayoutRetained Earnings

NATIONAL HEALTHCARE CORP

NYSEARCA:NHC (2/20/2026, 8:04:00 PM)

After market: 157.82 0 (0%)

157.82

-0.6 (-0.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-31
Earnings (Next)02-25
Inst Owners62.44%
Inst Owner Change3.98%
Ins Owners7.07%
Ins Owner Change-0.2%
Market Cap2.45B
Revenue(TTM)1.50B
Net Income(TTM)101.25M
Analysts60
Price TargetN/A
Short Float %3%
Short Ratio4.98
Dividend
Industry RankSector Rank
Dividend Yield 1.62%
Yearly Dividend2.4
Dividend Growth(5Y)3.3%
DP37.72%
Div Incr Years11
Div Non Decr Years11
Ex-Date03-31
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 24.35
Fwd PE N/A
P/S 1.63
P/FCF 16.68
P/OCF 13.53
P/B 2.33
P/tB 2.84
EV/EBITDA 12.25
EPS(TTM)6.48
EY4.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.46
FCFY6%
OCF(TTM)11.67
OCFY7.39%
SpS96.69
BVpS67.85
TBVpS55.58
PEG (NY)N/A
PEG (5Y)3.03
Graham Number99.46
Profitability
Industry RankSector Rank
ROA 6.44%
ROE 9.62%
ROCE 9.63%
ROIC 7.14%
ROICexc 9.28%
ROICexgc 11.49%
OM 8.27%
PM (TTM) 6.75%
GM 38.55%
FCFM 9.79%
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
ROICexc(3y)4.49%
ROICexc(5y)5.97%
ROICexgc(3y)5.54%
ROICexgc(5y)6.99%
ROCE(3y)4.96%
ROCE(5y)6.21%
ROICexgc growth 3Y-4%
ROICexgc growth 5Y11.11%
ROICexc growth 3Y-3.17%
ROICexc growth 5Y7.37%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.5
Debt/EBITDA 0.39
Cap/Depr 76.7%
Cap/Sales 2.28%
Interest Coverage 250
Cash Conversion 107.3%
Profit Quality 145.05%
Current Ratio 1.75
Quick Ratio 1.72
Altman-Z 4.95
F-Score6
WACC8.58%
ROIC/WACC0.83
Cap/Depr(3y)68.9%
Cap/Depr(5y)71.13%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.77%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-8.28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.12%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%12.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.96%
EBIT growth 3Y3.3%
EBIT growth 5Y11.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y102.62%
FCF growth 3Y51.34%
FCF growth 5Y1.58%
OCF growth 1Y85.86%
OCF growth 3Y19.81%
OCF growth 5Y1.4%

NATIONAL HEALTHCARE CORP / NHC FAQ

What is the fundamental rating for NHC stock?

ChartMill assigns a fundamental rating of 6 / 10 to NHC.


Can you provide the valuation status for NATIONAL HEALTHCARE CORP?

ChartMill assigns a valuation rating of 3 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Overvalued.


How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?

NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 8 / 10.


How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?

The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 37.72%.